MGAT3 and non-Hodgkin lymphoma: In addition, CHO cells transfected with GnTIII are utilized in industry for the production of antibodies that significantly improve antibody-dependent cellular cytotoxicity and treat neuroblastoma and non-Hodgkin's lymphoma [34], [35].